In the phase III CodeBreaK 300 study, sotorasib 960 mg-panitumumab significantly prolonged progression-free survival (PFS) versus investigator’s choice (trifluridine/tipiracil or regorafenib) in patients with KRAS G12C-mutated chemorefractory metastatic …
The integration of artificial intelligence (AI) and machine learning (ML) in oncology clinical trials is rapidly evolving alongside the broader field. For example, AI-driven adaptive…
Population-based cancer surveillance across the United States is a critical public health effort, identifying trends in incidence and mortality and understanding epidemiology and environmental and…
Bispecific antibodies (bsAbs) have emerged as a novel class of therapeutics, offering a dual-targeting strategy to enhance the therapeutic efficacy of monoclonal antibodies, which is…
The 2025 ASCO Annual Meeting Program will feature over 200 sessions complementing Dr. Robin Zon’s Presidential theme, Driving Knowledge to Action: Building a Better Future.…
PURPOSE The study of rare diseases, such as multiple myeloma (MM), often experiences unique research hurdles that can delay or prevent lifesaving discoveries. HealthTree Cure…
View all available purchase options and get full access to this article. The following represents disclosure information provided by authors of this manuscript. All relationships…
The 2025 ASCO Annual Meeting Program will feature over 200 sessions complementing Dr. Robin Zon’s Presidential theme, Driving Knowledge to Action: Building a Better Future.…
View all available purchase options and get full access to this article. The following represents disclosure information provided by authors of this manuscript. All relationships…
PURPOSEAs the complexity and need for cancer care services continue to grow, time to treatment initiation (TTI) has been increasing across cancer types. Presently there…
